Patents Undermine Drug Innovation and Access by Gabby Couture
The U.S. patent system hinders genuine biomedical innovation by rewarding pharmaceutical companies for manipulating the patent process, rather than for developing legitimate treatments that benefit many. Policy reform is necessary to boost true innovation and lower drug prices.Pharmaceutical companies argue that high drug prices are...